Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T

Conditions: T-cell Lymphoma Interventions: Biological: hNeo-T; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: BGI, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials